Literature DB >> 17530729

Synthesis and evaluation of 3-phenylpyrazolo[3,4-d]pyrimidine-peptide conjugates as Src kinase inhibitors.

Anil Kumar1, Yuehao Wang, Xiaofeng Lin, Gongqin Sun, Keykavous Parang.   

Abstract

3-Phenylpyrazolo[3,4-d]pyrimidine (PhPP) derivatives substituted with an alkyl or aryl carboxylic acid at the N1-endocyclic amine, such as PhPP-CH(2)COOH (IC(50)=250 microM), and peptides Ac-CIYKYY (IC(50)=400 microM) and Ac-YIYGSFK (IC(50)=570 microM) were weak inhibitors of polyE(4)Y phosphorylation by active c-Src. A series of PhPP-peptide conjugates were synthesized using PhPP as an ATP mimic and CIYKYY or YIYGSFK as a peptide substrate to improve the inhibitory potency against active c-Src kinase. PhPP derivatives were attached to the N terminus or the side chain of amino acids in the peptide template. Two N-terminal substituted conjugates, PhPP-CH(2)CO-CIYKYY (IC(50)=0.38 microM) and PhPP-CH(2)CO-YIYGSFK (IC(50)=2.7 microM), inhibited the polyE(4)Y phosphorylation by active c-Src significantly higher than that of the parent compounds. The conjugation of PhPP with the peptides produced a synergistic inhibition effect possibly through creation of favorable interactions between the conjugate and the kinase domain as shown by molecular modeling studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17530729     DOI: 10.1002/cmdc.200700074

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  5 in total

1.  Peptide-conjugated pterins as inhibitors of ricin toxin A.

Authors:  Ryota Saito; Jeff M Pruet; Lawrence A Manzano; Karl Jasheway; Arthur F Monzingo; Paul A Wiget; Ishan Kamat; Eric V Anslyn; Jon D Robertus
Journal:  J Med Chem       Date:  2012-12-19       Impact factor: 7.446

2.  Cyclic peptides containing tryptophan and arginine as Src kinase inhibitors.

Authors:  Amir Nasrolahi Shirazi; Rakesh Kumar Tiwari; Alex Brown; Dindyal Mandal; Gongqin Sun; Keykavous Parang
Journal:  Bioorg Med Chem Lett       Date:  2013-04-06       Impact factor: 2.823

3.  Design, Synthesis, and Biological Evaluation of Proteolysis Targeting Chimeras (PROTACs) for the Dual Degradation of IGF-1R and Src.

Authors:  Sudhakar Manda; Na Keum Lee; Dong-Chan Oh; Jeeyeon Lee
Journal:  Molecules       Date:  2020-04-23       Impact factor: 4.411

4.  Rational drug-design approach supported with thermodynamic studies - a peptide leader for the efficient bi-substrate inhibitor of protein kinase CK2.

Authors:  Maria Winiewska-Szajewska; Dawid Płonka; Igor Zhukov; Jarosław Poznański
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

5.  4-Aryl-4H-naphthopyrans derivatives: one-pot synthesis, evaluation of Src kinase inhibitory and anti-proliferative activities.

Authors:  Ali Rafinejad; Asal Fallah-Tafti; Rakesh Tiwari; Amir Nasrolahi Shirazi; Deendayal Mandal; Abbas Shafiee; Keykavous Parang; Alireza Foroumadi; Tahmineh Akbarzadeh
Journal:  Daru       Date:  2012-12-26       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.